← Back to Volume 4

Recent Advances of Nanozymes as Therapies for ROS-Induced Diseases

Jiabao Shi
pp.109-117 DOI: 10.62051/8xzp5k10 August 29, 2024
Download PDF
Abstract: Recently nanozymes have received more and more attention and have been applied in many fields. Recent advances of applications of nanozymes as therapies for various reactive oxygen species (ROS)-induced diseases are summarized in this account. For each case, the rational design strategies as well as various factors regulating the multiple enzyme-like activities, are also discussed. Perspectives and Challenges are also mentioned.
Keywords: Nanozymes, therapeutics, inflammation, ROS -related diseases.
APA Citation: Jiabao Shi (2024). Recent Advances of Nanozymes as Therapies for ROS-Induced Diseases. Transactions on Materials, Biotechnology and Life Sciences, 4(1), 109-117. https://doi.org/10.62051/8xzp5k10

References

  1. a) Mao M, Guan X, Wu F and Ma L 2022 Nanomaterials 12 638; b) Chen Y, Chen T, Wu X and Yang G 2019 Sens. Actuators B 279 374; c) Wang Z, Wu J, Zheng J, Shen X, Yan L, Wei H, Gao X and Zhao Y 2021, Nat. Commun. 12 6866; d) Song C, Liu H, Zhang L, Wang J, Zhao C, Xu Q and Yao C 2022 Sens. Actuators B 353 131131
  2. Bhagat S, Srikanth V N V, Shutthanandan V, Bowden M, Karakoti A S and Singh S 2018 J. Colloid Interface Sci. 222 701
  3. a) Tian R, Ma H, Ye W, Li Y, Wang S, Zhang Z, Liu S, Zang M, Hou J, Xu J, Lu Q, Sun H, Ba F, Yang Y and Liu J 2022 Adv. Funct. Mater. 32 2204025; b) Ali A, Ovais M, Zhou H, Rui Y and Chen C 2021 Biomaterials 275 120951
  4. Sheng J, Wu Y, Ding H, Feng K, Shen Y, Zhang Y and Gu N 2024 Adv. Mater. 36 2211210
  5. a) Yang B, Chen Y and Shi J 2019 Chem. Rev. 119 4881; b) Yang B, Chen Y, Shi J, 2019 Adv. Mater. 31 1901778
  6. Zhao S, Li Y, Liu Q, Li S, Cheng Y, Cheng C, Sun Z, Du Y, Butch C J and Wei H 2020 Adv. Funct. Mater. 30 2004692
  7. Muhammad F, Huang F, Cheng Y, Chen X, Wang Q, Zhu C, Zhang Y, Yang X, Wang P and Wei H 2022 ACS Nano 16 20567
  8. Wang Q, Cheng C, Zhao S, Liu Q, Zhang Y, Liu W, Zhao X, Zhang H, Pu J, Zhang S, Zhang H, Du Y and Wei H 2022 Angew. Chem. Int. Ed. 61 e202201101
  9. Zhang C, Wang H, Yang X, Fu Z, Ji X, Shi Y, ZHONG J , Hu W , YE Y, Wang Z and Ni D 2022 Sci. Adv. 8 eabp9882
  10. Hou L, Gong F, Liu B, Yang X, Chen L, Li G, Gong Y, Liang C, Yang N, Shen X, Liu Z and Cheng L 2022 Theranostics 12 3834
  11. Yu Y, Zhao X, Xu X, Cai C, Tang X, Zhang Q, Zhong L, Zhou F, Yang D and Zhu Z 2023 Adv. Mater. 35 2304967
  12. Selman M, King T and Pardo A 2001 Ann Intern Med. 134 136
  13. Hassan A I, Samir A, Youssef H F, Mohamed S S, Asker M S and Mahmoud M G 2021 J. Pharm. Pharmacol. 73 1503
  14. Krusic P J, Wasserman E, Keizer P N, Morton J R and Preston K F 1991 Science 254 1183
  15. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson S R and Moussa F 2005 Nano Lett. 5 2578
  16. Dong R, Liu, M, Huang X, Liu Z, Jiang D, Xiao H and Dai H 2020 Int. J. Nanomedicine 15 2269
  17. Liu Q, Ren Y, Jia H, Yuan H, Tong Y, Sumasri K, Mao X, Huang Y, Chen C, Zheng Z, Wang L and He W 2023 ACS Nano 17 22527
  18. Liu Y, Mao Y, Xu E, Jia H, Zhang S, Dawson V L, Dawson T M, Li Y, Zheng Z, He W and Mao X 2021 Nano Today 36 101027
  19. Jia Z, Yuan X, Wei J, Guo X, Gong Y, Li J, Zhou H, Zhang L and Liu J 2021 ACS Appl. Mater. Interf. 13 49602